News

Introducing patient-centric SARS-CoV-2 serology testing with Trajan Scientific and Medical and Synexa Life Sciences

Introducing patient-centric SARS-CoV-2 serology testing with Trajan Scientific and Medical and Synexa Life Sciences

In response to the COVID-19 pandemic, the biopharmaceutical industry has leapt into action to better understand the disease and develop suitable vaccines and therapies. Trajan Scientific and Medical and Synexa Life Sciences have developed and validated an innovative, market-leading SARS-CoV-2 serology assay, available for high-throughput clinical research applications, using Trajan's advanced precision microsampling technology to expedite therapy and vaccine development as well as large-scale screening, sero-surveillance and post-market surveillance initiatives.

With hemaPEN’s® innovative, easy-to-use design and microsampling technology, large scale screening and sero-surveillance studies post-vaccine roll out can be conducted safely and efficiently, while maintaining social distancing protocols and maintaining patient-centricity, comfort and convenience.

Combining this technology with Synexa’s innovative, market-leading SARS-CoV-2 serology assay - a versatile technology capable of detecting IgG, IgM, IgA and nAb antibody response, as well as their semi-quantification without the need for titration - has yielded a highly competitive and flexible assay, suitable across a wide range of applications.

Through this collaboration, Trajan and Synexa have developed a powerful platform to enable vaccine programs with more convenience and comfort for the patient, while retaining high quality data for understanding the safety and efficacy of vaccines.

If you would like more information about our product and service offering to assist and support your vaccine program, please contact us.

Download
Brochure - SARS-CoV-2 serology testing

Related news
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC's Analyst

More information
www.hemapen.com

Media contact information
Trajan Scientific and Medical
Tel: +44 (0) 1908 568 844
media@trajanscimed.com

Also in news

News Trajan Scientific and Medical receives ISO 13485 certification
Trajan Scientific and Medical receives ISO 13485 certification

Trajan Scientific and Medical has obtained the ISO 13485:2016 certification at both its Ringwood headquarters and Penang, Malaysia site. This certification marks a testa...

News Bridging the HDX gap with Monash and Trajan
Bridging the HDX gap with Monash and Trajan

Monash University has recently implemented Trajan's HDX Extended System within its Proteomics and Metabolomics Platform (MPMP), forging a collaborative effort aimed at n...

News Trajan collaborates with University of Melbourne's Faculty of Science on Student Industry Projects
Trajan collaborates with University of Melbourne's Faculty of Science on Student Industry Projects

Since 2017, Trajan Scientific and Medical has supported 12 industry projects with The University of Melbourne's Faculty of Science, in the Master of Biotechnology and Master of Data Science degrees.